Literature DB >> 25956407

Cervical Cancer Screening Among Adult Women in China, 2010.

Baohua Wang1, Minfu He1, Ann Chao1, Michael M Engelgau1, Mona Saraiya1, Limin Wang1, Linhong Wang2.   

Abstract

INTRODUCTION: Cervical cancer is one of the most commonly diagnosed cancers among women in China. The World Health Organization (WHO) recommends routine screening for cervical cancer, and the WHO Global Monitoring Framework suggests that every nation monitors cervical cancer screening. However, little information is available on cervical cancer screening behavior among women in China.
METHODS: We used data from the 2010 China Chronic Disease and Risk Factor Surveillance System that included 51,989 women aged 18 years and older. We report the proportion of women who reported ever having had a Papanicolaou (Pap) test, stratified by sociodemographic characteristics and geographic region. Multivariable logistic regression modeling was performed to adjust for potential confounders.
RESULTS: Overall, 21% of 51,989 women reported having ever had a Pap test. The highest proportion was reported among women aged 30-39 years (30.1%, 95% confidence interval, 26.8%-33.4%). In all geographic regions, women in rural areas were consistently less likely than women in urban areas to report having had a Pap test. Among women who reported ever having a Pap test, 82% reported having the most recent test in the past 3 years. Factors associated with reporting ever having a test were being aged 30-49 years, higher education, being married, and having urban health insurance.
CONCLUSION: Our results indicate that screening programs need to be strengthened along with a more intense focus on specific demographic groups. National cervical cancer screening guidelines and comprehensive implementation strategies are needed to make screening services available and accessible to all women. IMPLICATIONS FOR PRACTICE: This study is the largest nationwide and population-based assessment of self-reported history of Pap test for cervical cancer screening in China. This article describes cervical cancer screening behavior among women and examines key demographic and geographic factors. Only one fifth of Chinese women reported having ever had a Pap test for cervical cancer screening. The results highlight the urgent need to develop national cervical cancer screening guidelines and strategies that make screening services widely available, accessible, and acceptable to all women, especially to those who reside in rural areas and those with no health insurance. ©AlphaMed Press.

Entities:  

Keywords:  Cervical cancer; China; Epidemiology; Papanicolaou test; Women

Mesh:

Year:  2015        PMID: 25956407      PMCID: PMC4571778          DOI: 10.1634/theoncologist.2014-0303

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  22 in total

Review 1.  Socio-economic status, forms of capital and obesity.

Authors:  Stanley J Ulijaszek
Journal:  J Gastrointest Cancer       Date:  2012-03

2.  Cancer screening - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-01-27       Impact factor: 17.586

3.  Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Authors:  Rengaswamy Sankaranarayanan; Pulikkottil Okkuru Esmy; Rajamanickam Rajkumar; Richard Muwonge; Rajaraman Swaminathan; Sivanandam Shanthakumari; Jean-Marie Fayette; Jacob Cherian
Journal:  Lancet       Date:  2007-08-04       Impact factor: 79.321

4.  A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China.

Authors:  Fang-Hui Zhao; Sarah M Tiggelaar; Shang-Ying Hu; Li-Na Xu; Ying Hong; Mayinuer Niyazi; Xiao-Hong Gao; Li-Rong Ju; Li-Qin Zhang; Xiang-Xian Feng; Xian-Zhi Duan; Xiu-Ling Song; Jing Wang; Yun Yang; Chang-Qing Li; Jia-Hua Liu; Ji-Hong Liu; Yu-Bo Lu; Li Li; Qi Zhou; Jin-feng Liu; Na Zhao; Johannes E Schmidt; You-Lin Qiao
Journal:  Cancer Epidemiol       Date:  2012-02-27       Impact factor: 2.984

5.  Cooperative medical schemes in contemporary rural China.

Authors:  X Feng; S Tang; G Bloom; M Segall; Y Gu
Journal:  Soc Sci Med       Date:  1995-10       Impact factor: 4.634

6.  Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.

Authors:  Lynette Denny; Louise Kuhn; Michelle De Souza; Amy E Pollack; William Dupree; Thomas C Wright
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

7.  Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.

Authors:  L Gaffikin; P D Blumenthal; M Emerson; K Limpaphayom
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

8.  How does the New Cooperative Medical Scheme influence health service utilization? A study in two provinces in rural China.

Authors:  Baorong Yu; Qingyue Meng; Charles Collins; Rachel Tolhurst; Shenglan Tang; Fei Yan; Lennart Bogg; Xiaoyun Liu
Journal:  BMC Health Serv Res       Date:  2010-05-10       Impact factor: 2.655

9.  Measuring health care access and quality to improve health in populations.

Authors:  Thomas E Kottke; George J Isham
Journal:  Prev Chronic Dis       Date:  2010-06-15       Impact factor: 2.830

10.  Tackling the challenges to health equity in China.

Authors:  Shenglan Tang; Qingyue Meng; Lincoln Chen; Henk Bekedam; Tim Evans; Margaret Whitehead
Journal:  Lancet       Date:  2008-10-17       Impact factor: 79.321

View more
  47 in total

1.  Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.

Authors:  Xiaomeng Ma; Katherine Harripersaud; Kumi Smith; Christopher K Fairley; Huachun Zou; Zhuoru Zou; Yueyun Wang; Guihua Zhuang; Lei Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

2.  Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.

Authors:  Rodrigo Lopes da Silva; Zulmira da Silva Batista; Gerusinete Rodrigues Bastos; Ana Paula Almeida Cunha; Fábio Vidal Figueiredo; Lailson Oliveira de Castro; Liwerbeth Dos Anjos Pereira; Marcos Antonio Custódio Neto da Silva; Flávia Castello Branco Vidal; Maria Claudene Barros; Elmary da Costa Fraga; Luciane Maria Oliveira Brito; Maria do Carmo Lacerda Barbosa; Miguel Ângelo Martins Moreira; Maria do Desterro Soares Brandão Nascimento
Journal:  BMC Womens Health       Date:  2020-08-01       Impact factor: 2.809

3.  Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.

Authors:  Min Wei; Wei Zhou; Yongyi Bi; Hong Wang; Yu Liu; Zhi-Jiang Zhang
Journal:  J Gen Intern Med       Date:  2018-11-27       Impact factor: 5.128

4.  Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.

Authors:  Zhezhou Huang; Ying Zheng; Wanqing Wen; Chunxiao Wu; Pingping Bao; Chunfang Wang; Weijian Zhong; Yu-Tang Gao; Fan Jin; Yong-Bing Xiang; Xiao-Ou Shu; Alicia Beeghly-Fadiel
Journal:  Eur J Cancer       Date:  2016-05-26       Impact factor: 9.162

Review 5.  The Tsinghua-Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China.

Authors:  Jun Yang; José G Siri; Justin V Remais; Qu Cheng; Han Zhang; Karen K Y Chan; Zhe Sun; Yuanyuan Zhao; Na Cong; Xueyan Li; Wei Zhang; Yuqi Bai; Jun Bi; Wenjia Cai; Emily Y Y Chan; Wanqing Chen; Weicheng Fan; Hua Fu; Jianqing He; Hong Huang; John S Ji; Peng Jia; Xiaopeng Jiang; Mei-Po Kwan; Tianhong Li; Xiguang Li; Song Liang; Xiaofeng Liang; Lu Liang; Qiyong Liu; Yongmei Lu; Yong Luo; Xiulian Ma; Bernhard Schwartländer; Zhiyong Shen; Peijun Shi; Jing Su; Tinghai Wu; Changhong Yang; Yongyuan Yin; Qiang Zhang; Yinping Zhang; Yong Zhang; Bing Xu; Peng Gong
Journal:  Lancet       Date:  2018-04-17       Impact factor: 79.321

6.  Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014.

Authors:  Xueting Li; Rongshou Zheng; Xuemei Li; Haibin Shan; Qi Wu; Yan Wang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

7.  Trends in geographical disparities for cervical cancer mortality in China from 1973 to 2013: a subnational spatio-temporal study.

Authors:  Changfa Xia; Chao Ding; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Jinfeng Wang; Yilan Liao; Ningxu Zhang; Zhixun Yang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

8.  Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study.

Authors:  Binhua Dong; Huachun Zou; Xiaodan Mao; Yingying Su; Hangjing Gao; Fang Xie; Yuchun Lv; Yaojia Chen; Yafang Kang; Huifeng Xue; Diling Pan; Pengming Sun
Journal:  Ther Adv Med Oncol       Date:  2021-04-28       Impact factor: 8.168

9.  miR-4417 targets lncRNA PSMG3-AS1 to suppress cell invasion and migration in cervical squamous cell carcinoma.

Authors:  Shuhong Man; Xiaohan Li; Wei Zhu
Journal:  Oncol Lett       Date:  2021-04-29       Impact factor: 2.967

10.  SOX14 hypermethylation as a tumour biomarker in cervical cancer.

Authors:  Jing Zhao; Huiling Cao; Wenfan Zhang; Yongjuan Fan; Shujuan Shi; Rong Wang
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.